{"transactions":[{"id":4616228,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-11T21:44:32.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each outstanding restricted stock unit (\"RSU\"), subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such RSU immediately prior to the Effective Time multiplied by (2) $6.75 and (B) one CVR for each share subject to such RSU immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each outstanding restricted stock unit (\"RSU\"), subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such RSU immediately prior to the Effective Time multiplied by (2) $6.75 and (B) one CVR for each share subject to such RSU immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each outstanding restricted stock unit (\"RSU\"), subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such RSU immediately prior to the Effective Time multiplied by (2) $6.75 and (B) one CVR for each share subject to such RSU immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each outstanding restricted stock unit (\"RSU\"), subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such RSU immediately prior to the Effective Time multiplied by (2) $6.75 and (B) one CVR for each share subject to such RSU immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-26-036390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036390/form4.xml","form_type":"4"}},{"id":4616227,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-09-11T21:44:32.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":675000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001140361-26-036390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036390/form4.xml","form_type":"4"}},{"id":4616226,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-09-11T21:44:32.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":673808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":673808},"source":{"system":"sec-edgar","filing":"0001140361-26-036390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036390/form4.xml","form_type":"4"}},{"id":4616225,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-09-11T21:44:32.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":372701,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.84,"expiration_date":"2034-03-13","underlying":"Common Stock","underlying_shares":372701},"source":{"system":"sec-edgar","filing":"0001140361-26-036390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036390/form4.xml","form_type":"4"}},{"id":4616224,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-09-11T21:44:32.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28608,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.18,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":28608},"source":{"system":"sec-edgar","filing":"0001140361-26-036390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036390/form4.xml","form_type":"4"}},{"id":4616223,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-09-11T21:44:32.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":2.86,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":50400},"source":{"system":"sec-edgar","filing":"0001140361-26-036390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036390/form4.xml","form_type":"4"}},{"id":4616222,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-09-11T21:44:32.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":5.54,"expiration_date":"2032-02-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-26-036390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036390/form4.xml","form_type":"4"}},{"id":4616221,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-11T21:44:32.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of July 15, 2026, by and among AtaiBeckley Inc. (the \"Company\"), Eli Lilly and Company, an Indiana corporation (\"Parent\"), and Albali Acquisition Corporation, a Delaware corporation and indirect wholly owned subsidiary of Parent (\"Merger Sub\"), on September 11, 2026, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each share of the Company's common stock, par value $0.01 per share, issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, converted into the right to receive (i) $6.75 per share in cash, without interest, plus (ii) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-26-036390","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036390/form4.xml","form_type":"4"}},{"id":724429,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-29T22:00:39.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":9528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested as to 25% of the underlying shares on March 14, 2024, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":28608,"derivative":{"exercise_price":1.18,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":9528},"source":{"system":"sec-edgar","filing":"0001140361-26-026787","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126026787/form4.xml","form_type":"4"}},{"id":724428,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-29T22:00:39.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":33051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on January 1, 2026, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":673808,"derivative":{"exercise_price":1.5,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":33051},"source":{"system":"sec-edgar","filing":"0001140361-26-026787","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126026787/form4.xml","form_type":"4"}},{"id":724427,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:00:39.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":42579,"price":4.51,"value":192031.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $4.50 to $4.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price"}],"balance_after":8437,"source":{"system":"sec-edgar","filing":"0001140361-26-026787","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126026787/form4.xml","form_type":"4"}},{"id":724426,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:00:39.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":9528,"price":1.18,"value":11243.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":51016,"source":{"system":"sec-edgar","filing":"0001140361-26-026787","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126026787/form4.xml","form_type":"4"}},{"id":724425,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:00:39.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":33051,"price":1.5,"value":49576.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":41488,"source":{"system":"sec-edgar","filing":"0001140361-26-026787","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126026787/form4.xml","form_type":"4"}},{"id":803089,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-22T21:32:52.000Z","date":"2026-04-20","kind":"exercise","planned":true,"acquired":false,"shares":15299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on January 1, 2025, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":372701,"derivative":{"exercise_price":1.84,"expiration_date":"2034-03-13","underlying":"Common Stock","underlying_shares":15299},"source":{"system":"sec-edgar","filing":"0001140361-26-016169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126016169/form4.xml","form_type":"4"}},{"id":803088,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-22T21:32:52.000Z","date":"2026-04-20","kind":"exercise","planned":true,"acquired":false,"shares":27280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on January 1, 2026, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":706859,"derivative":{"exercise_price":1.5,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":27280},"source":{"system":"sec-edgar","filing":"0001140361-26-016169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126016169/form4.xml","form_type":"4"}},{"id":803087,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-22T21:32:52.000Z","date":"2026-04-20","kind":"sale","planned":true,"acquired":false,"shares":42579,"price":5,"value":212895.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":8437,"source":{"system":"sec-edgar","filing":"0001140361-26-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126016169/form4.xml","form_type":"4"}},{"id":803086,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-22T21:32:52.000Z","date":"2026-04-20","kind":"exercise","planned":true,"acquired":true,"shares":15299,"price":1.84,"value":28150.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":51016,"source":{"system":"sec-edgar","filing":"0001140361-26-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126016169/form4.xml","form_type":"4"}},{"id":803085,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-22T21:32:52.000Z","date":"2026-04-20","kind":"exercise","planned":true,"acquired":true,"shares":27280,"price":1.5,"value":40920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":35717,"source":{"system":"sec-edgar","filing":"0001140361-26-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126016169/form4.xml","form_type":"4"}},{"id":829633,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-24T22:01:28.000Z","date":"2026-03-20","kind":"exercise","planned":true,"acquired":false,"shares":23776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.52 to $3.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":734139,"derivative":{"exercise_price":1.5,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":23776},"source":{"system":"sec-edgar","filing":"0001140361-26-010932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126010932/form4.xml","form_type":"4"}},{"id":829632,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-24T22:01:28.000Z","date":"2026-03-20","kind":"exercise","planned":true,"acquired":false,"shares":76224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":38136,"derivative":{"exercise_price":1.18,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":76224},"source":{"system":"sec-edgar","filing":"0001140361-26-010932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126010932/form4.xml","form_type":"4"}},{"id":829631,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-24T22:01:28.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":3.55,"value":355000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock option vested as to 25% of the underlying shares on March 14, 2024, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":8437,"source":{"system":"sec-edgar","filing":"0001140361-26-010932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126010932/form4.xml","form_type":"4"}},{"id":829630,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-24T22:01:28.000Z","date":"2026-03-20","kind":"exercise","planned":true,"acquired":true,"shares":23776,"price":1.5,"value":35664.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":108437,"source":{"system":"sec-edgar","filing":"0001140361-26-010932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126010932/form4.xml","form_type":"4"}},{"id":829629,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-24T22:01:28.000Z","date":"2026-03-20","kind":"exercise","planned":true,"acquired":true,"shares":76224,"price":1.18,"value":89944.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":84661,"source":{"system":"sec-edgar","filing":"0001140361-26-010932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126010932/form4.xml","form_type":"4"}},{"id":922449,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T23:54:00.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-26-003547","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126003547/form4.xml","form_type":"4"}},{"id":922448,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-03T23:54:00.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying the option on January 1, 2027 and as to the remaining 75% of the total number of shares in 36 substantially equal monthly installments thereafter."}],"balance_after":675000,"derivative":{"exercise_price":3.76,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001140361-26-003547","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126003547/form4.xml","form_type":"4"}},{"id":1193776,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-03-25T01:00:09.000Z","date":"2025-03-21","kind":"sale","planned":false,"acquired":false,"shares":11563,"price":1.35,"value":15610.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units."}],"balance_after":8437,"source":{"system":"sec-edgar","filing":"0001140361-25-010115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2049601/000114036125010115/form4.xml","form_type":"4"}},{"id":1197419,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T23:29:49.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. The restricted stock units vested on March 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. The restricted stock units vested on March 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. The restricted stock units vested on March 14, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-25-009514","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2049601/000114036125009514/form4.xml","form_type":"4"}},{"id":1197418,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-03-19T23:29:49.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. The restricted stock units vested on March 14, 2025."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001140361-25-009514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2049601/000114036125009514/form4.xml","form_type":"4"}},{"id":1220100,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":34883,"kind":"person","name":"Craig Kevin James","position":1,"cik":"0002049601","reported_name":"Craig Kevin James","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-03-06T14:06:40.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":757915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest as to 25% on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":757915,"derivative":{"exercise_price":1.5,"expiration_date":"2035-03-03","underlying":"Common Shares","underlying_shares":757915},"source":{"system":"sec-edgar","filing":"0001140361-25-007334","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2049601/000114036125007334/form4.xml","form_type":"4"}}]}